Diagnosis and therapy of adult type-2 inflammation chronic rhinosinusitis: a systematic literature review
DOI:
https://doi.org/10.31101/ijhst.v7i3.4508Abstract views 0 times
Keywords:
chronic rhinosinusitis, therapy, type-2Abstract
Adult type-2 inflammation chronic rhinosinusitis with nasal polyp impacts quality of life. Despite diagnosis and treatment advances, recurrence is common, prompting the exploration of new diagnosis and therapies. Objectives To review the current literature for the best diagnosis and therapy of adult type-2 inflammation chronic rhinosinusitis and future research to find new specific diagnoses and therapies. We conducted a literature review of PubMed, Google Scholar, Cochrane Library and others, August, 2 - 9, 2025. The search terms included “type-2 inflammation”, “chronic rhinosinusitis”, and “therapy”. We got 107 e-journals from: PubMed: 13, Google scholar: 11, Cochrane Library: 14, Others: 69. Type 2 inflammation is responsible for driving the disease in 80% to 90% of patients with nasal polyps (CRSwNP) and biomarkers for diagnosis include tissue/blood eosinophils, total IgE, and interleukin. Type 2 inflamation CRSwNP have high recurrence rates 38% to 60% at 12 months follow-up, and resistance to conventional medical or surgical treatment. Effectiveness of recent treatment for severe type 2 CRSwNP: corticosteroid effective for rapid reduction of inflammation, Endoscopic Sinus Surgery (ESS) is effective for restoring sinus drainage, and biological agents promosing future treatment. Future studies should investigate the optimal diagnostic techniques for individual patients based on underlying pathophysiology especially endotype and biomarker to better direct treatment and should assess the role of new therapies. The treatment of corticosteroid combine with antihistamine, new biologics agent and new surgery technic promising strategy for achieving therapeutic benefits type-2 inflammation chronic rhinosinusitis.
Downloads
References
Ahern, S., & Vince, A. (2019). Inflammation and Endotyping in Chronic Rhinosinusitis - A Paradigm Shift. Medicina, 55(4), 95. https://doi.org/10.3390/medicina55040095
Al-Ahmad, M., Alsaleh, S., Al-Reefy, H., Al Abduwani, J., Nasr, I., Al Abri, R., Alamadi, A. M. H., Fraihat, A. A., Alterki, A., Abuzakouk, M., Marglani, O., & Rand, H. A. (2022). Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. Journal of Asthma and Allergy, Volume 15, 1–12. https://doi.org/10.2147/JAA.S321017
Albu, S. (2020). Chronic Rhinosinusitis-An Update on Epidemiology, Pathogenesis and Management. Journal of Clinical Medicine, 9(7), 2285. https://doi.org/10.3390/jcm9072285
Aldajani, A., Alroqi, A., Alramyan, R., Alhejin, N., Alswayyed, M., Alrajban, W. A., Alromaih, S., Aloulah, M. O., Alrasheed, A. S., Aldousary, S., & Alsaleh, S. (2024). Prevalence of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in Saudi Arabia. Frontiers in Surgery, 11, 1421140. https://doi.org/10.3389/fsurg.2024.1421140
Al-Fraihat, A. A., Malek, A. I., Pelletier, A., Endam, L., Desrosiers, M., & Hamadi, I. (2025). Cross-Regional Comparison of Type 2 Inflammatory Markers in Chronic Rhinosinusitis With Nasal Polyposis: Insights From the Gulf Region and Canada. Cureus. https://doi.org/10.7759/cureus.87500
Almutairi, A., Aloraini, L. Y., Alshahrani, B. M., Alzuhairi, M. O., Alzanadi, R. H., Alanazi, K. F., Khubrani, Y. A., & Azzam, A. Y. (2025). Comparative efficacy and safety of monoclonal antibodies biologic therapies for chronic rhinosinusitis with nasal polyps: A systematic review and network meta-analysis. American Journal of Otolaryngology, 46(6), 104734. https://doi.org/10.1016/j.amjoto.2025.104734
Al-sharif, S., Jonstam, K., Van Zele, T., Gevaert, P., Holtappels, G., & Bachert, C. (2019). Endoscopic Sinus Surgery for Type‐2 CRS wNP: An Endotype‐Based Retrospective Study. The Laryngoscope, 129(6), 1286–1292. https://doi.org/10.1002/lary.27815
Bachert, C., Corren, J., Lee, S. E., Zhang, H., Harel, S., Cunoosamy, D., Khan, A. H., Jacob‐Nara, J. A., Siddiqui, S., Nash, S., Rowe, P. J., & Deniz, Y. (2022). Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. International Forum of Allergy & Rhinology, 12(9), 1191–1195. https://doi.org/10.1002/alr.22964
Bachert, C., Hellings, P. W., Mullol, J., Hamilos, D. L., Gevaert, P., Naclerio, R. M., Joish, V. N., Chao, J., Mannent, L. P., Amin, N., Abbe, A., Taniou, C., Fan, C., Pirozzi, G., Graham, N. M. H., Mahajan, P., Staudinger, H., & Khan, A. (2020). Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy, 75(1), 148–157. https://doi.org/10.1111/all.13984
Bachert, C., Hicks, A., Gane, S., Peters, A. T., Gevaert, P., Nash, S., Horowitz, J. E., Sacks, H., & Jacob-Nara, J. A. (2024). The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps. Frontiers in Immunology, 15, 1356298. https://doi.org/10.3389/fimmu.2024.1356298
Bachert, C., Zhang, N., Hellings, P. W., & Bousquet, J. (2018). Endotype-driven care pathways in patients with chronic rhinosinusitis. Journal of Allergy and Clinical Immunology, 141(5), 1543–1551. https://doi.org/10.1016/j.jaci.2018.03.004
Barroso, B., Valverde-Monge, M., Betancor, D., Gómez-López, A., Villalobos-Vildas, C., González-Cano, B., & Sastre, J. (2023). Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. Journal of Investigational Allergy and Clinical Immunology, 33(6), 419–430. https://doi.org/10.18176/jiaci.0939
Barshak, M. B., & Durand, M. L. (2017). The role of infection and antibiotics in chronic rhinosinusitis. Laryngoscope Investigative Otolaryngology, 2(1), 36-42. https://doi.org/10.1002/lio2.61
Bartier, S., Coste, A., & Béquignon, E. (2021). Biotherapy and treatment of adult primary chronic rhinosinusitis with nasal polyps: Cellular and molecular bases. European Annals of Otorhinolaryngology, Head and Neck Diseases, 138(5), 355–362. https://doi.org/10.1016/j.anorl.2020.12.002
Bogaert, S., Rheindorf, E., Dazert, S., Volkenstein, S., Knipps, L., Park, J. J., & Pfaar, O. (2025). Quality of life in type 2 and non‐type 2 endotypes in chronic rhinosinusitis with nasal polyps: A prospective trial. Clinical and Translational Allergy, 15(6), e70070. https://doi.org/10.1002/clt2.70070
Brescia, G., Frosolini, A., Franz, L., Daloiso, A., Fantin, F., Lovato, A., Filippis, C. D., & Marioni, G. (2023). Chronic Otitis Media in Patients with Chronic Rhinosinusitis: A Systematic Review. Medicina, 59(1), 123. https://doi.org/10.3390/medicina59010123
Cai, S., Xu, S., Zhao, Y., & Zhang, L. (2025). Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence. Allergy, 80(5), 1256-1270. https://doi.org/10.1111/all.16499
Canevari, F. R., Giorli, A., Monti, G., Biagini, C., Bagnasco, D., Cavaliere, C., Pipolo, C., De Corso, E., Gelardi, M., Gramellini, G., Ioppi, A., La Mantia, I., Malvezzi, L., Bignami, M., Dehgani-Mobaraki, P., Seccia, V., Maggiore, G., & Macchi, A. (2023). Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis. Frontiers in Allergy, 4, 1237131. https://doi.org/10.3389/falgy.2023.1237131
Cantone, E., Gallo, S., Torretta, S., Detoraki, A., Cavaliere, C., Di Nola, C., Spirito, L., Di Cesare, T., Settimi, S., Furno, D., Pignataro, L., & De Corso, E. (2022). The Role of Allergen-Specific Immunotherapy in ENT Diseases: A Systematic Review. Journal of Personalized Medicine, 12(6), 946. https://doi.org/10.3390/jpm12060946
Cao, P.P., Wang, Z.C., Schleimer, R. P., & Liu, Z. (2019). Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Annals of Allergy, Asthma & Immunology, 122(1), 33–40. https://doi.org/10.1016/j.anai.2018.10.014
Casale, M., Moffa, A., Cassano, M., Carinci, F., Lopez, M. A., Trecca, E. M. C., Torretta, S., Rinaldi, V., & Pignataro, L. (2018). Saline nasal irrigations for chronic rhinosinusitis: From everyday practice to evidence-based medicine. An update. International Journal of Immunopathology and Pharmacology, 32, 2058738418802676. https://doi.org/10.1177/2058738418802676
Chen, M., Xu, M., Lei, X., & Zhang, B. (2022). Efficacy of Endoscopic Posterior Nasal Neurectomy in Treating Eosinophilic Chronic Rhinosinusitis. ORL, 84(4), 347–351. https://doi.org/10.1159/000519724
Chen, J., Wang, L., Wang, X., Zhang, Y., & Yang, Q. (2025). Treatment Approach to Chronic Rhinosinusitis Based on Endotype: Difference Between East and West. Clinical & Experimental Allergy, 55(11), 1052–1056. https://doi.org/10.1111/cea.70150
Chin, C. J., Scott, J. R., & Lee, J. M. (2025). Diagnosis and management of chronic rhinosinusitis. Canadian Medical Association Journal, 197(6), E148–E154. https://doi.org/10.1503/cmaj.241101
Chong, L.-Y., Piromchai, P., Sharp, S., Snidvongs, K., Webster, K. E., Philpott, C., Hopkins, C., & Burton, M. J. (2021). Biologics for chronic rhinosinusitis. Cochrane Database of Systematic Reviews, 2021(10). https://doi.org/10.1002/14651858.CD013513.pub3
De Greve, G., Hellings, P. W., Fokkens, W. J., Pugin, B., Steelant, B., & Seys, S. F. (2017). Endotype-driven treatment in chronic upper airway diseases. Clinical and Translational Allergy, 7(1), 22. https://doi.org/10.1186/s13601-017-0157-8
Delemare, T., Holtappels, G., De Ruyck, N., Zhang, N., Nauwynck, H., Bachert, C., & Gevaert, E. (2020). Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype. Journal of Allergy and Clinical Immunology, 146(2), 337-343.e6. https://doi.org/10.1016/j.jaci.2020.04.040
Dharmaputri, S., Lasminingrum, L., & Sofiatin, Y. (2017). Nasal Endoscopy Findings in Acute and Chronic Rhinosinusitis Patients. Althea Medical Journal. http://dx.doi.org/10.15850/amj.v4n3.1192
Fageeh, Y. A., Basurrah, M. A., Hakami, K. T., Almalki, Z. A., Alnemari, F. S., & Altalhi, W. A. (2023). Risk factors for recurrence of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery: A retrospective study. Saudi Medical Journal, 44(12), 1254-1259. https://doi.org/10.15537/smj.2023.44.12.20230396
Feng, Y., Meng, Y.-P., Dong, Y.-Y., Qiu, C.-Y., & Cheng, L. (2021). Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: A meta-analysis of current evidence. Allergy, Asthma & Clinical Immunology, 17(1), 62. https://doi.org/10.1186/s13223-021-00564-z
Fokkens, W. J., De Corso, E., Hellings, P. W., Harvey, R. J., Hopkins, C., & Reitsma, S. (2025). Algorithm for the Management of Primary Diffuse Chronic Rhinosinusitis. Allergy, 80(1), 359–361. https://doi.org/10.1111/all.16417
Ghadersohi, S., & Tan, B. K. (2017). Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis. Otolaryngologic Clinics of North America, 50(6), 1135-1151. https://doi.org/10.1016/j.otc.2017.08.009
Giombi, F., Pace, G. M., Pirola, F., Cerasuolo, M., Ferreli, F., Mercante, G., Spriano, G., Canonica, G. W., Heffler, E., Ferri, S., Puggioni, F., Paoletti, G., & Malvezzi, L. (2024). Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? International Journal of Molecular Sciences, 25(2), 730. https://doi.org/10.3390/ijms25020730
Giri, S., Schneider, A. L., & Tan, B. K. (2022). Chronic rhinosinusitis: Future treatments and unmet needs. Journal of Allergy and Clinical Immunology, 150(2), 287–290. https://doi.org/10.1016/j.jaci.2022.05.016
Giunta, G., Pirola, F., Giombi, F., Muci, G., Pace, G. M., Heffler, E., Paoletti, G., Puggioni, F., Cerasuolo, M., Ferreli, F., Salamanca, F., Mercante, G., Spriano, G., Canonica, G. W., & Malvezzi, L. (2023). Care for Patients with Type-2 Chronic Rhinosinusitis. Journal of Personalized Medicine, 13(4), 618. https://doi.org/10.3390/jpm13040618
Hassoun, D., Malard, O., Barbarot, S., Magnan, A., & Colas, L. (2021). Type 2 immunity‐driven diseases: Towards a multidisciplinary approach. Clinical & Experimental Allergy, 51(12), 1538-1552. https://doi.org/10.1111/cea.14029
Hildenbrand, T., Milger-Kneidinger, K., Baumann, I., & Weber, R. (2024). The diagnosis and treatment of chronic rhinosinusitis. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.m2024.0167
Homøe, A., Aanæs, K., Tidemandsen, J. E., Holbaek, H. C., Niclas, R., Badsberg, S. G., Holmegaard, L. B. I., & Backer, V. (2025). Superior Benefits of Combining Mepolizumab With Sinus Surgery Compared to Mepolizumab Alone: Results From a Randomised 6‐Month Trial. International Forum of Allergy & Rhinology, 15(7), 724–733. https://doi.org/10.1002/alr.23562
Hopkins, C., Mullol, J., Khan, A. H., Lee, S. E., Wagenmann, M., Hellings, P., Fokkens, W., Msihid, J., Nair, R., Kamat, S., Nash, S., Radwan, A., Jacob‐Nara, J. A., Deniz, Y., & Rowe, P. J. (2024). Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps. Otolaryngology–Head and Neck Surgery, 170(4), 1173-1182. https://doi.org/10.1002/ohn.627
Hu, W., Zuo, Q., Wu, D., & Song, Y. (2025). A novel and effective surgical procedure for posterior nasal Huneurectomy in patients with allergic rhinitis. Brazilian Journal of Otorhinolaryngology, 91(5), 101653. https://doi.org/10.1016/j.bjorl.2025.101653
Jonstam, K., Swanson, B. N., Mannent, L. P., Cardell, L., Tian, N., Wang, Y., Zhang, D., Fan, C., Holtappels, G., Hamilton, J. D., Grabher, A., Graham, N. M. H., Pirozzi, G., & Bachert, C. (2019). Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy, 74(4), 743–752. https://doi.org/10.1111/all.13685
Kariyawasam, H. H., Chandrasekharan, D. P., Jacques, T., Stokes, P., Dziadzio, M., Gane, S. B., Langan, D., & Rimmer, J. (2023). Biologic treatment for severe chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis. Rhinology Journal, 61(2), 98–107. https://doi.org/10.4193/Rhin22.412
Kato, A., Schleimer, R. P., & Bleier, B. S. (2022). Mechanisms and pathogenesis of chronic rhinosinusitis. Journal of Allergy and Clinical Immunology, 149(5), 1491-1503. https://doi.org/10.1016/j.jaci.2022.02.016
Khalaf, A. S., Jumaah, Y. S. and. Hadeed, S.M., (2025). Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Pathophysiology and Advances in Treatment Options. https://doi.org/10.24412/2500-2295-2025-4-61-69
Kim, J., & Naclerio, R. (2020). Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date. Therapeutics and Clinical Risk Management, Volume 16, 31–37. https://doi.org/10.2147/TCRM.S210648
Kim, J.S., Stybayeva, G., & Hwang, S. H. (2025). Efficacy of vidian neurectomy in treating chronic rhinosinusitis with nasal polyps combined with allergic rhinitis: A systematic review and meta-analysis. Auris Nasus Larynx, 52(1), 28–34. https://doi.org/10.1016/j.anl.2024.12.004
Kim, J.W., Won, T.B., Woo, H., Yang, S. K., Phannikul, C., Ko, S. A., Kim, H., Rhee, C.-S., & Cho, S.-W. (2022). Age related non-type 2 inflammation and its association with treatment outcome in patients with chronic rhinosinusitis with nasal polyp in Korea. Scientific Reports, 12(1), 1671. https://doi.org/10.1038/s41598-022-05614-z
Klimek, L., Förster-Ruhrmann, U., Olze, H., Beule, A. G., Chaker, A. M., Hagemann, J., Huppertz, T., Hoffmann, T. K., Dazert, S., Deitmer, T., Strieth, S., Wrede, H., Schlenter, W. W., Welkoborsky, H.-J., Wollenberg, B., Becker, S., Bärhold, F., Klimek, F., Casper, I., Bachert, C. (2024). Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy? Allergologie Select, 8(1), 26–39. https://doi.org/10.5414/ALX02460E
Kratchmarov, R., Dharia, T., & Buchheit, K. (2025). Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology, 155(5), 1401-1410. https://doi.org/10.1016/j.jaci.2025.03.011
Laidlaw, T. M., Mullol, J., Woessner, K. M., Amin, N., & Mannent, L. P. (2021). Chronic Rhinosinusitis with Nasal Polyps and Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 9(3), 1133-1141. https://doi.org/10.1016/j.jaip.2020.09.063
Lee, S. E., Hopkins, C., Mullol, J., Msihid, J., Guillemin, I., Amin, N., Mannent, L. P., Li, Y., Siddiqui, S., Chuang, C., Kamat, S., & Khan, A. H. (2022). Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies. Allergy, 77(7), 2211-2221. https://doi.org/10.1111/all.15222
Leland, E. M., Vohra, V., Seal, S. M., Zhang, Z., & Ramanathan, M. (2022). Environmental air pollution and chronic rhinosinusitis: A systematic review. Laryngoscope Investigative Otolaryngology, 7(2), 349–360. https://doi.org/10.1002/lio2.774
Li, J., Kang, H., Hong, S., & Shen, Y. (2021). Effect of Postoperative Specific Immunotherapy Combined with Nasal Irrigation on Chronic Rhinosinusitis with Allergic Rhinitis. Iranian Journal of Allergy, Asthma and Immunology. https://doi.org/10.18502/ijaai.v20i4.6953
Liu, L., Pan, M., Li, Y., Tan, G., & Yang, Y. (2020). Efficacy of nasal irrigation with hypertonic saline on chronic rhinosinusitis: Systematic review and meta-analysis. Brazilian Journal of Otorhinolaryngology, 86(5), 639–646. https://doi.org/10.1016/j.bjorl.2020.03.008
Lommatzsch, M., Blumchen, K., Beck, L. A., Bousquet, J., Brusselle, G. G., Fokkens, W. J., Hamelmann, E., Lau, S., Ott, H., Pfaar, O., Sampson, H. A., Smolen, J. S., Taube, C., Tarner, I. H., Wagenmann, M., Werfel, T., Worm, M., & Renz, H. (2025). Roads to remission: Evolving treatment concepts in type 2 inflammatory diseases. eClinicalMedicine, 80, 103050. https://doi.org/10.1016/j.eclinm.2024.103050
Lou, H., & Zhang, L. (2022). Knowledge gaps in using type 2 biologics for real‐world treatment of chronic rhinosinusitis with nasal polyps. Allergy, 77(7), 1952–1954. https://doi.org/10.1111/all.15307
Makihara, S., Okano, M., Miyamoto, S., Uraguchi, K., Tsumura, M., Kariya, S., & Ando, M. (2021). Underwater posterior nasal neurectomy compared to resection of peripheral branches of posterior nerve in severe allergic rhinitis. Acta Oto-Laryngologica, 141(8), 780-785. https://doi.org/10.1080/00016489.2021.1925151
Marin, C., Hummel, T., Liu, Z., & Mullol, J. (2022). Chronic Rhinosinusitis and COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 10(6), 1423-1432. https://doi.org/10.1016/j.jaip.2022.03.003
Marshak, T., Yun, W. K., Hazout, C., Sacks, R., & Harvey, R. J. (2016). A systematic review of the evidence base for vidian neurectomy in managing rhinitis. The Journal of Laryngology & Otology, 130(S4), S7-S28. https://doi.org/10.1017/S0022215116008008
Martin-Jimenez, D., Moreno-Luna, R., Cuvillo, A., Gonzalez-Garcia, J., Maza-Solano, J., & Sanchez-Gomez, S. (2023). Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review. Current Allergy and Asthma Reports, 23(12), 733-746. https://doi.org/10.1007/s11882-023-01113-x
Maspero, J., Adir, Y., Al-Ahmad, M., Celis-Preciado, C. A., Colodenco, F. D., Giavina-Bianchi, P., Lababidi, H., Ledanois, O., Mahoub, B., Perng, D.-W., Vazquez, J. C., & Yorgancioglu, A. (2022). Type 2 inflammation in asthma and other airway diseases. ERJ Open Research, 8(3), 00576-02021. https://doi.org/10.1183/23120541.00576-2021
Matsunaga, K., Koarai, A., Koto, H., Shirai, T., Muraki, M., Yamaguchi, M., Hanaoka, M., Matsunaga, K., Koarai, A., Koto, H., Shirai, T., Muraki, M., Yamaguchi, M., Hanaoka, M., Asako, M., Asano, K., Ichikawa, T., Ueki, S., Oishi, K., Fuke, S. (2025). Guidance for type 2 inflammatory biomarkers. Respiratory Investigation, 63(3), 273-288. https://doi.org/10.1016/j.resinv.2025.01.003
Mawkili, A. A., Alghazi, J. H., Alqahtani, A. M., Alshalwan, M. A., Essa, S. A. M., Alissa, G. I., Althobaiti, A. I., Alsuwayyid, R. Y., Alzahrani, S. E., Alaidarous, S. T., & Ayoub, A. Y. (2025). The Efficacy and Safety of Intranasal Corticosteroids in Chronic Rhinosinusitis: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.87674
Miglani, A., Divekar, R. D., Azar, A., Rank, M. A., & Lal, D. (2018). Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype. International Forum of Allergy & Rhinology, 8(9), 1047-1051. https://doi.org/10.1002/alr.22146
Mora, T., Sánchez‐Collado, I., Muñoz‐Cano, R., Ribó, P., Palomo‐Jiménez, P. I., Mullol, J., & Valero, A. (2024). Prevalence and coexistence of type 2 inflammatory diseases. Clinical and Translational Allergy, 14(6), e12376. https://doi.org/10.1002/clt2.12376
Mortuaire, G., Gengler, I., Balden, M., Capron, M., & Lefèvre, G. (2018). Impact of allergy on phenotypic and endotypic profiles of nasal polyposis. European Annals of Otorhinolaryngology, Head and Neck Diseases, 135(3), 159–162. https://doi.org/10.1016/j.anorl.2017.11.005
Mullol, J., Bachert, C., Amin, N., Desrosiers, M., Hellings, P. W., Han, J. K., Jankowski, R., Vodicka, J., Gevaert, P., Daizadeh, N., Khan, A. H., Kamat, S., Patel, N., Graham, N. M. H., Ruddy, M., Staudinger, H., & Mannent, L. P. (2022). Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps. The Journal of Allergy and Clinical Immunology: In Practice, 10(4), 1086-1095.e5. https://doi.org/10.1016/j.jaip.2021.09.037
Nappi, E., Marzio, V., Giombi, F., Costanzo, G., Merli, S., Nicolosi, S., Cavaglià, E., Rizzini, F. L., Traversi, S., Vrenna, A., Vassallo, S., Pace, G. M., Lombardi, C., Rossi, C. M., Puggioni, F., Malvezzi, L., Canonica, G. W., Paoletti, G., & Heffler, E. (2025). Chronic rhinosinusitis with and without nasal polyps: The state-of-the-art of current treatment strategies and future developments. Frontiers in Allergy, 6, 1714577. https://doi.org/10.3389/falgy.2025.1714577
Narasimhan, G., Deshmukh, P. T., Gaurkar, S. S., & Khan, F. Q. (2024). A Comprehensive Review Exploring Allergic Rhinitis With Nasal Polyps: Mechanisms, Management, and Emerging Therapies. Cureus. https://doi.org/10.7759/cureus.59191
Neri, G., Cazzato, F., Vestrini, E., La Torre, P., Quaternato, G., Neri, L., & Centurione, L. (2019). Turbinate Surgery in Chronic Rhinosinusitis: Techniques and Ultrastructural Outcomes. In B. Singh Gendeh & M. Turkalj (Eds.), Rhinosinusitis. IntechOpen. https://doi.org/10.5772/intechopen.84506
Nugroho, A., Katili, P. A., & Rahman, S. F. (2022). Chronic rhinosinusitis on radiological examination: Literature review. International Journal of Health Science and Technology, 4(2), 198-204. https://doi.org/10.31101/ijhst.v4i2.2752
Orlando, P., Licci, G., Kuitche, D., Matucci, A., Vultaggio, A., Gallo, O., & Maggiore, G. (2024). Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: A preliminary report. European Archives of Oto-Rhino-Laryngology, 281(3), 1317-1324. https://doi.org/10.1007/s00405-023-08309-x
Otten, J., Van Der Lans, R., De Corso, E., Dziadziulia, K., Hilvering, B., Weersink, E., Bonini, M., Hagemann, J., Thaitrakool, W., Montuori, C., Klimek, L., Reitsma, S., & Fokkens, W. (2023). Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making. Expert Review of Clinical Immunology, 19(8), 1041–1049. https://doi.org/10.1080/1744666X.2023.2218617
Padia, R., Curtin, K., Peterson, K., Orlandi, R. R., & Alt, J. (2016). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. The Laryngoscope, 126(6), 1279–1283. https://doi.org/10.1002/lary.25798
Park, D.Y., Choi, J. H., Kim, D.K., Jung, Y. G., Mun, S. J., Min, H. J., Park, S. K., Shin, J.M., Yang, H. C., Hong, S.N., & Mo, J.H. (2022). Clinical Practice Guideline: Nasal Irrigation for Chronic Rhinosinusitis in Adults. Clinical and Experimental Otorhinolaryngology, 15(1), 5-23. https://doi.org/10.21053/ceo.2021.00654
Patel, G. B., & Peters, A. T. (2021). The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Ear, Nose & Throat Journal, 100(1), 44–47. https://doi.org/10.1177/0145561320964653
Pelletier, A., Endam, L. M., Gonzalez, E., Jannat, S., Irani, T., & Desrosiers, M. (2025). Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP. International Forum of Allergy & Rhinology, 15(3), 227–238. https://doi.org/10.1002/alr.23471
Pirola, F., Vezzoli, E., Falqui, A., Giombi, F., Heffler, E., Mercante, G., Spriano, G., Grizzi, F., & Malvezzi, L. (2025). Nasal Mucosa Regeneration After Reboot Surgery: Electron Microscopy and Histology Insights in CRSWNP. The Laryngoscope, 135(9), 3082–3092. https://doi.org/10.1002/lary.32166
Putera, A. M., Hikmah, Z., Endaryanto, A., Irwanto, & Maramis, M. M. (2021). The role of house dust mite immunotherapy in Indonesian children with chronic rhinosinusitis allergy: A randomized control trial. Heliyon, 7(3), e06510. https://doi.org/10.1016/j.heliyon.2021.e06510
Qi, L., & Feng, X. (2025). Precision endotyping and management of type 2 chronic rhinosinusitis with nasal polyps. Annals of Allergy, Asthma & Immunology, 135(2), 131-132. https://doi.org/10.1016/j.anai.2025.05.013
Ramkumar, S. P., Lal, D., & Miglani, A. (2023). Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps. Frontiers in Allergy, 4, 1137907. https://doi.org/10.3389/falgy.2023.1137907
Ren, L., Zhang, N., Zhang, L., & Bachert, C. (2019). Biologics for the treatment of chronic rhinosinusitis with nasal polyps - State of the art. World Allergy Organization Journal, 12(8), 100050. https://doi.org/10.1016/j.waojou.2019.100050
Sahnoon, L., Bajbouj, K., Mahboub, B., Hamoudi, R., & Hamid, Q. (2025). Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma. Clinical Reviews in Allergy & Immunology, 68(1), 44. https://doi.org/10.1007/s12016-025-09045-2
Seccia, V., D’Amato, M., Scioscia, G., Bagnasco, D., Di Marco, F., Fadda, G., Menzella, F., Pasquini, E., Pelaia, G., Tremante, E., De Corso, E., & Bonini, M. (2022). Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach. Journal of Personalized Medicine, 12(7), 1096. https://doi.org/10.3390/jpm12071096
Sedaghat, A. R., Kuan, E. C., & Scadding, G. K. (2022). Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors. The Journal of Allergy and Clinical Immunology: In Practice, 10(6), 1395-1403. https://doi.org/10.1016/j.jaip.2022.01.016
Seresirikachorn, K., Khattiyawittayakun, L., Chitsuthipakorn, W., & Snidvongs, K. (2018). Antihistamines for treating rhinosinusitis: Systematic review and meta-analysis of randomised controlled studies. The Journal of Laryngology & Otology, 132(2), 105-110. https://doi.org/10.1017/S002221511700192X
Seresirikachorn, K., Mullol, J., Limitlaohaphan, K., Asvapoositkul, V., & Snidvongs, K. (2021). Leukotriene receptor antagonist addition to intranasal steroid: Systematic review and meta-analysis. Rhinology Journal, 59(1), 2–9. https://doi.org/10.4193/Rhin20.126
Sheikh, M. A., Patigaroo, S. A., Showkat, S. A., Latoo, M. A., & Rather, R. H. (2024). The validity of clinical guidelines and nasal endoscopy in the diagnosis of chronic rhinosinusitis - A prospective observational study. The Egyptian Journal of Otolaryngology, 40(1), 80. https://doi.org/10.1186/s43163-024-00644-y
Simmons, J. K., Leiman, D. A., Patil, S. U., McCoul, E., Chen, P. G., Tang, D. M., Kuan, E. C., Chang, E. E., & Wu, A. W. (2022). Increased Prevalence of Eosinophilic Esophagitis in Patients With Chronic Rhinosinusitis. American Journal of Rhinology & Allergy, 36(6), 804–807. https://doi.org/10.1177/19458924221116162
Smith, S. S., Kim, R., & Douglas, R. (2022). Is there a role for antibiotics in the treatment of chronic rhinosinusitis? Journal of Allergy and Clinical Immunology, 149(5), 1504–1512. https://doi.org/10.1016/j.jaci.2022.02.004
Soyka, M. B., Ryser, F. S., Brühlmann, C., Fehr, D., Dülgeroglu, J., Schmid‐Grendelmeier, P., Brüggen, M., & Steiner, U. C. (2023). Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis. Allergy, 78(4), 1036–1046. https://doi.org/10.1111/all.15532
Studer, M. B., Roland, L. T., Ochsner, M. C., Cox, D., DelGaudio, J. M., Wise, S. K., & Levy, J. M. (2020). Aspirin-Exacerbated Respiratory Disease With Allergic Fungal Rhinosinusitis: A Case Series of Overlapping Sinonasal Endotypes. American Journal of Rhinology & Allergy, 34(3), 422-427. https://doi.org/10.1177/1945892420903587
Sun, S., Chen, A., Shi, L., & Wan, Y. (2024). Two types of vidian neurectomy show efficacy in treating allergic rhinitis and vasomotor rhinitis. Scientific Reports, 14(1), 27303. https://doi.org/10.1038/s41598-024-78116-9
Tai, J., Han, M., & Kim, T. H. (2022). Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets. International Journal of Molecular Sciences, 23(10), 5523. https://doi.org/10.3390/ijms23105523
Tamene, S., Dalhoff, K., Schwarz, P., Backer, V., & Aanaes, K. (2023). Systemic corticosteroids in treatment of chronic rhinosinusitis-A systematic review. European Clinical Respiratory Journal, 10(1), 2240511. https://doi.org/10.1080/20018525.2023.2240511
Thomas, R. M., Jamaldeen, J., Kurien, M (2019). Turbinectomy In Chronic Inferior Turbinate Hypertrophy- A Safe Surgical Alternative. MedPulse International Journal of ENT, 12(2), 70-74. https://doi.org/10.26611/101612214
Tomé, M., & Lourenço, O. (2023). Avoidance Measures for Patients with Allergic Rhinitis: A Scoping Review. Children, 10(2), 300. https://doi.org/10.3390/children10020300
Toppila-Salmi, S., Bjermer, L., Cardell, L.-O., Cervin, A., Heinikari, T., Lehtimäki, L., Lundberg, M., Richter, J., & Sillanpää, S. (2024). Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights. Journal of Asthma and Allergy, Volume 17, 431-439. https://doi.org/10.2147/JAA.S447093
Van Boven, F. E., Braunstahl, G.-J., Arends, L. R., Van Maaren, M. S., Bramer, W. M., Van Wijk, R. G., & De Jong, N. W. (2024). House dust mite allergen avoidance strategies for the treatment of allergic asthma: A hypothesis-generating meta-analysis. World Allergy Organization Journal, 17(6), 100919. https://doi.org/10.1016/j.waojou.2024.100919
Wallace, D.V. (2021) Treatment option for chronic rhinosinusitis with nasal polys. Allergy and Asthma proceeding, 42(6), 450-460. https://doi.org/10.2500/aap.2021.42.210080
Weissman, B., Shen, K., Flanagan, O. L., Chowdhury, S., & Sawires, J. (2025). Comparing Medical and Surgical Management of Chronic Rhinosinusitis: A Systematic Review of Dupilumab and Endoscopic Sinus Surgery. Cureus. https://doi.org/10.7759/cureus.79742
Wiedermann, J., Bury, S. B., & Singh, A. (n.d.). Endoscopic Diagnosis of Chronic Rhinosinusitis. Yang, C., Guo, L., Wang, Y., Jiang, W., Chen, S., & Gu, Q. (2025). The advance on pathophysiological mechanisms of type 2 chronic rhinosinusitis with nasal polyposis. Frontiers in Allergy, 6, 1599797. https://doi.org/10.3389/falgy.2025.1599797
Xu, X., Lin, J., Luo, M., & Wu, Q. (2025). Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta‐Analysis. Clinical and Translational Allergy, 15(11), e70114. https://doi.org/10.1002/clt2.70114
Yang, C., Guo, L., Wang, Y., Jiang, W., Chen, S., & Gu, Q. (2025). The advance on pathophysiological mechanisms of type 2 chronic rhinosinusitis with nasal polyposis. Frontiers in Allergy, 6, 1599797. https://doi.org/10.3389/falgy.2025.1599797
Yao, Y., Zeng, M., & Liu, Z. (2022). Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics. Clinical & Experimental Allergy, 52(2), 231–243. https://doi.org/10.1111/cea.14065
Zheng, M., Hao, W., Meng, Q., & Cherrabi, K. (2025). Biologic Agents in the Treatment of Severe Chronic Rhinosinusitis with Nasal Polyps in Adults: A Systematic Review and Meta-Analysis. Journal of Clinical Question, 2(4), e79. https://doi.org/10.69854/jcq.2025.0016
Zhu, H., Qu, S., Gong, M., Xiang, Y., Gan, S., Teng, Y., & Ye, D. (2025). Mechanisms, diagnosis, and treatment of olfactory dysfunction in rhinosinusitis. European Journal of Medical Research, 30(1), 474. https://doi.org/10.1186/s40001-025-02740-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Budi Santoso, Dinar Rosmala
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
International Journal of Health Science and Technology allows readers to read, download, copy, distribute, print, search, or link to its articles' full texts and allows readers to use them for any other lawful purpose. The journal allows the author(s) to hold the copyright without restrictions. Finally, the journal allows the author(s) to retain publishing rights without restrictions
- Authors are allowed to archive their submitted article in an open access repository
- Authors are allowed to archive the final published article in an open access repository with an acknowledgment of its initial publication in this journal
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 Generic License.
